Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Meet Our Team

 

Editorial Staff

Senior Managing Editor: Meagan Thistle
mthistle@hmpglobal.com

Associate Editor: Brionna Mendoza
bmendoza@hmpglobal.com

Associate Editor: Evi Arthur
earthur@hmpglobal.com

Business Staff

Sales Director: Mark Kennedy
mkennedy@hmpglobal.com

National Accounts, Psychiatry & Behavioral Health Learning Network: pbhlnsales@hmpglobal.com

 

Advertisement

Advertisement

Advertisement

Popular Now

ketamine brain image
News
Study Findings Support Esketamine and Psilocybin as Effective TRD Treatments
05/14/2024
Meagan Thistle
To address the challenges and “inadequate outcomes” with monoamine-based therapies, a Toronto-based research team investigated novel alternatives for TRD.
To address the challenges and “inadequate outcomes” with monoamine-based therapies, a Toronto-based research team investigated novel alternatives for TRD.
To address the challenges and...
05/14/2024
Psych Congress Network
Videos
AIMS Exam Instructional Video
01/05/2018
Psych Congress co-chair Rakesh Jain, MD, MPH, explains the importance of the Abnormal Involuntary Movement Scale (AIMS) exam in the diagnosis and monitoring of patients with tardive dyskinesia.
Psych Congress co-chair Rakesh Jain, MD, MPH, explains the importance of the Abnormal Involuntary Movement Scale (AIMS) exam in the diagnosis and monitoring of patients with tardive dyskinesia.
Psych Congress co-chair Rakesh...
01/05/2018
Psychiatry & Behavioral Health
News
One Year After ‘X Waiver’ Axing, Few New Patients Prescribed Meds for OUD
05/15/2024
Brionna Mendoza
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of buprenorphine prescribers increased following the elimination of the X waiver in January 2023, the total number of patients using the medication to manage opioid use disorder (OUD) “changed little.”
Though the number of...
05/15/2024
Psych Congress Network
Jonathan Meyer
Videos
The ‘Gold Standard:’ Lithium as a Mood Stabilizer for Patients With Bipolar Disorder
10/12/2023

With Jonathan Meyer, MD

With Jonathan Meyer, MD
Dr Jonathan Meyer on lithium use in treatment
Dr Jonathan Meyer on lithium use in treatment
Dr Jonathan Meyer on lithium use...
10/12/2023
Psych Congress Network
Understanding the ‘Neurochemical Alphabet’ to Inform Treatment
Videos
Understanding the ‘Neurochemical Alphabet’ to Inform Treatment
11/28/2023
In his recent NEI Congress session, Vladimir Maletic, MD, MS, University of South Carolina, Greenville, examined the neurobiologic underpinning of major psychiatric conditions such as major depressive disorder, bipolar disorder, and anxiety....
In his recent NEI Congress session, Vladimir Maletic, MD, MS, University of South Carolina, Greenville, examined the neurobiologic underpinning of major psychiatric conditions such as major depressive disorder, bipolar disorder, and anxiety....
In his recent NEI Congress...
11/28/2023
Psychiatry & Behavioral Health

Advertisement

Advertisement

Advertisement

Sign Up

Psychiatry & Behavioral Health Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement